businessbriefs
10:44in productionCh. 1 · Delayed by the FTC/ 10:44 · ceiling 15 min
Deals & IPOs

Nutrien

2018

A merger sold as a fix for low fertilizer prices delivered cost cuts — but no proof it could raise prices.

Nutrien is a textbook post-merger entity: built for cost discipline, not innovation; structured for scale, not agility; and defined by what it acquired, not what it invented.

Deals & IPOsAgricultureCapitalismComedyAgriculture across the network →
Chapters & takeaways4
  1. 1:09
    Delayed by the FTC

    The merger closed a year late due to U.S. regulatory intervention.

  2. 2:38
    Savings, Not Pricing Power

    Cost savings were guaranteed; price increases were only hoped for.

  3. 4:19
    The World’s Largest Potash Producer

    Scale came from vertical integration: mining, manufacturing, and retail across three continents.

  4. 6:33
    Born From Merger, Not Market

    Nutrien is Canadian, headquartered in Saskatoon, and exists only because of a 2018 merger — not organic growth.

Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • cost reduction target
  • global retail footprint
  • potash production leadership
What does not
  • prove pricing power
  • achieve merger timing target
  • establish new market position beyond scale
Study it if
  • dealmakers
  • commodity analysts
  • regulatory watchers
Skip it if
  • startups
  • tech investors
  • consumer brand strategists
The written brief1 min read

What the company or idea is

Nutrien is a Canadian fertilizer company formed on 1 January 2018 through the merger of PotashCorp and Agrium.

How it actually makes money

Nutrien makes money by producing and selling potash and nitrogen fertilizers, and by operating a global retail network of over 2,000 locations that sell crop inputs directly to farmers.

What works

The merger achieved scale: Nutrien became the world’s largest potash producer and second-largest nitrogen fertilizer producer, with over 2,000 retail locations and more than 23,500 employees.

What does not

The merger did not deliver immediate pricing power: it closed a year late, after U.S. FTC approval, and its stated aim to increase prices was contingent on market conditions it could not control.

What to take from it

Consolidation in low-margin commodity industries creates cost savings on paper — but those savings are structural, not strategic, and do not automatically translate into pricing leverage or resilience.

Is it worth your time

Yes — as a case study in how commodity consolidation is sold as efficiency, while pricing power remains unproven and regulatory concessions drive early strategy.

Same desk · Deals & IPOs4 of 12
10:34
Breakup of the Bell SystemThe Bell System breakup was a judicial demolition of vertical integration — enforced by antitrust law, executed via consent decree, and undone by later legislation. It transferred assets, not autonomy.
10:39
Sunrise LLC2021Sunrise LLC is a Swiss telecom provider whose business model is defined by ownership transfers—not service differentiation. It charges for bundled connectivity, but the source material reveals nothing about unit economics, churn, or network investment. Its story is one of serial financial engineering: CVC’s 2015 IPO, Liberty Global’s $7.4 billion acquisition in November 2020, and a post-acquisition re-listing claimed—but not verified—in the introductory text. The gap between that narrative and the verified facts is where the real brief lies.
10:25
E-Plus1992E-Plus was a licensed mobile operator in Germany, built on spectrum rights, not differentiation. It scaled to 25 million subscribers but could not defend its position against consolidation pressures. Its sale to Telefónica Germany was approved only after mandated divestments — revealing that scale alone does not confer strategic autonomy in regulated infrastructure markets.
9:49
SyngentaSwiss chemical-agricultural · 2000Syngenta is a global agricultural technology company headquartered in Basel, Switzerland, operating primarily in crop protection and seeds for farmers. It was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca. In 2004, Syngenta Seeds purchased Garst and Golden Harvest Seeds. In February 2016, ChemChina offered to purchase Syngenta for $43 billion, a deal Syngenta unanimously recommended to shareholders. In April 2017, U.S. and European antitrust authorities approved ChemChina's acquisition of Syngenta. To secure regulatory approval, ChemChina agreed to divest pesticide production of paraquat, abamectin, and chlorothalonil.
Up next in Business

New York Stock Exchange

1792 · 10:33

The NYSE isn’t a marketplace — it’s a members’ club that turned itself into infrastructure.

Play nextBack to Deals & IPOs
10:33